JPH0788379B2 - ２位置にα―ヒドロキシル鎖が置換した４―ヒドロキシ―３―キノリンカルボン酸より誘導される新エステル及びその製造法 - Google Patents

２位置にα―ヒドロキシル鎖が置換した４―ヒドロキシ―３―キノリンカルボン酸より誘導される新エステル及びその製造法

Info

Publication number
JPH0788379B2
JPH0788379B2 JP60240735A JP24073585A JPH0788379B2 JP H0788379 B2 JPH0788379 B2 JP H0788379B2 JP 60240735 A JP60240735 A JP 60240735A JP 24073585 A JP24073585 A JP 24073585A JP H0788379 B2 JPH0788379 B2 JP H0788379B2
Authority
JP
Japan
Prior art keywords
carbon atoms
substituted
group
alkyl group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60240735A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61109770A (ja
Inventor
フランソワ・クレマンス
オデイル・ル・マルトレ
フランソワーズ・ドレバレ
Original Assignee
ルセル―ユクラフ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ルセル―ユクラフ filed Critical ルセル―ユクラフ
Publication of JPS61109770A publication Critical patent/JPS61109770A/ja
Publication of JPH0788379B2 publication Critical patent/JPH0788379B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP60240735A 1984-10-30 1985-10-29 ２位置にα―ヒドロキシル鎖が置換した４―ヒドロキシ―３―キノリンカルボン酸より誘導される新エステル及びその製造法 Expired - Lifetime JPH0788379B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR84-16573 1984-10-30
FR8416573A FR2572404B2 (fr) 1984-10-30 1984-10-30 Nouveaux derives de l'acide 4-oh-3-quinoleine carboxylique substitues en 2, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Publications (2)

Publication Number Publication Date
JPS61109770A JPS61109770A (ja) 1986-05-28
JPH0788379B2 true JPH0788379B2 (ja) 1995-09-27

Family

ID=9309131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60240735A Expired - Lifetime JPH0788379B2 (ja) 1984-10-30 1985-10-29 ２位置にα―ヒドロキシル鎖が置換した４―ヒドロキシ―３―キノリンカルボン酸より誘導される新エステル及びその製造法

Country Status (14)

Country Link
US (1) US4735951A (https=)
EP (1) EP0183584B1 (https=)
JP (1) JPH0788379B2 (https=)
KR (1) KR920008822B1 (https=)
AT (1) ATE48424T1 (https=)
AU (1) AU601942B2 (https=)
CA (1) CA1259072A (https=)
DE (1) DE3574592D1 (https=)
ES (2) ES8702360A1 (https=)
FR (1) FR2572404B2 (https=)
GR (1) GR852568B (https=)
HU (1) HU197327B (https=)
PT (1) PT81391B (https=)
ZA (1) ZA857945B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
JPH02237443A (ja) * 1989-03-07 1990-09-20 Matsushita Electric Ind Co Ltd コアレスモータの回転子
JPH06501465A (ja) * 1990-09-07 1994-02-17 シェリング・コーポレーション 抗ウイルス化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus

Also Published As

Publication number Publication date
CA1259072A (fr) 1989-09-05
AU601942B2 (en) 1990-09-27
AU4917385A (en) 1986-05-08
ZA857945B (en) 1986-12-30
EP0183584A1 (fr) 1986-06-04
JPS61109770A (ja) 1986-05-28
EP0183584B1 (fr) 1989-12-06
HU197327B (en) 1989-03-28
GR852568B (https=) 1986-02-21
DE3574592D1 (de) 1990-01-11
PT81391B (pt) 1988-02-17
ES8702360A1 (es) 1987-01-01
HUT40649A (en) 1987-01-28
FR2572404B2 (fr) 1987-12-11
ES8800162A1 (es) 1987-11-01
KR860003250A (ko) 1986-05-21
FR2572404A2 (fr) 1986-05-02
ES556096A0 (es) 1987-11-01
ES548300A0 (es) 1987-01-01
PT81391A (fr) 1985-11-01
KR920008822B1 (ko) 1992-10-09
ATE48424T1 (de) 1989-12-15
US4735951A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
JPS61267580A (ja) チアゾリジン誘導体
GB2124077A (en) Immunomodulating agent
EP0151072B1 (fr) Dérivés de l'acide méthylènediphosphonique, procédé d'obtention et compositions pharmaceutiques antirhumatismales les contenant
US4350822A (en) Antilipidemicpara-[aryl(alkyl or alkenyl)amino]benzoic acid derivatives
JPS6356225B2 (https=)
US3860636A (en) Substituted indenyl phosphonic acids having anti-inflammatory activity
JPS62174012A (ja) フエニル脂肪族カルボン酸の新誘導体よりなる胃及び胃十二指腸潰瘍の治療用薬剤
GB1588352A (en) Indoleacetic acid ester derivatives
RU2126387C1 (ru) 2-циано-3-гидроксипропенамиды, способы их получения и фармацевтическая композиция на их основе
EP0051514B1 (fr) Dérivé d'acide cinnamoyl-cinnamique, son procédé de préparation et son application en thérapeutique
JPH0788379B2 (ja) ２位置にα―ヒドロキシル鎖が置換した４―ヒドロキシ―３―キノリンカルボン酸より誘導される新エステル及びその製造法
EP0153230B1 (fr) Nouveaux dérivés du pyrimido /2,1-b/ benzothiazole et leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
Mase et al. Imidazo [2, 1-b] benzothiazoles 3: syntheses and immunosuppressive activities of 2-(m-acyloxyphenyl) imidazo [2, 1-b] benzothiazoles
JPS63185948A (ja) 置換アミノプロピオンアミドおよびその製造方法
JPS6399057A (ja) グリシン誘導体
JPH0710863B2 (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
FR2468574A1 (fr) Derives de l'acide 4-chlorobiphenylalcoxy-acetique, procedes pour leur preparation et compositions pharmaceutiques en contenant
US4312869A (en) Monosubstituted piperazines
JPS584699B2 (ja) 置換フエニル酢酸誘導体及びその製法
EP0178073B1 (en) Amide compounds, process for preparing the same and pharmaceutical compositions containing the same
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
JPS6360015B2 (https=)
EP0121806A1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
JPS6324498B2 (https=)